+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Coherus Biosciences - logo
Avastin (Bevacizumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive/Terminated/Withdrawn Biosimilars, Industry/Non-Industry Partnerships - Product Thumbnail Image

Avastin (Bevacizumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive/Terminated/Withdrawn Biosimilars, Industry/Non-Industry Partnerships

  • Report
  • August 2021
  • 91 Pages
  • Global
From
Bevacizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Bevacizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Remicade Biosimilar Global Market Report 2023 - Product Thumbnail Image

Remicade Biosimilar Global Market Report 2023

  • Report
  • September 2023
  • 175 Pages
  • Global
From
Etanercept- Biosimilar Insight, 2022 - Product Thumbnail Image

Etanercept- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Adalimumab Biosimilar Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Adalimumab Biosimilar Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • March 2022
  • 95 Pages
  • Global
From
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Humira Drug Global Market Report 2023 - Product Thumbnail Image

Humira Drug Global Market Report 2023

  • Report
  • September 2023
  • 175 Pages
  • Global
From
Global Biosimilar Monoclonal Antibodies Market by Drug Class (Abciximab, Adalimumab, Bevacizumab), Application (Diagnostic, Protein Purification, Therapeutic) - Forecast 2023-2030 - Product Thumbnail Image

Global Biosimilar Monoclonal Antibodies Market by Drug Class (Abciximab, Adalimumab, Bevacizumab), Application (Diagnostic, Protein Purification, Therapeutic) - Forecast 2023-2030

  • Report
  • October 2023
  • 197 Pages
  • Global
From
Biosimilar Monoclonal Antibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Biosimilar Monoclonal Antibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • October 2023
  • 189 Pages
  • Global
From
Biosimilars and Follow-On Biologics Market Report 2023-2033 - Product Thumbnail Image

Biosimilars and Follow-On Biologics Market Report 2023-2033

  • Report
  • December 2022
  • 337 Pages
  • Global
From
US Cancer Biosimilar Market Opportunity, Drug Dosage, Price & Clinical Trials Insight 2026 - Product Thumbnail Image

US Cancer Biosimilar Market Opportunity, Drug Dosage, Price & Clinical Trials Insight 2026

  • Report
  • March 2021
  • 240 Pages
  • United States
From
Biosimilar Monoclonal Antibodies Global Market Report 2023 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies Global Market Report 2023

  • Report
  • February 2023
  • 250 Pages
  • Global
From
Global Biosimilar Monoclonal Antibodies (mAbs) Market 2021-2025 - Product Thumbnail Image

Global Biosimilar Monoclonal Antibodies (mAbs) Market 2021-2025

  • Report
  • July 2021
  • 120 Pages
  • Global
From
Global Biosimilars Partnering Terms and Agreements 2010 to 2023 - Product Thumbnail Image

Global Biosimilars Partnering Terms and Agreements 2010 to 2023

  • Report
  • June 2023
  • 150 Pages
  • Global
From
Biosimilar Monoclonal Antibody Market By Type, By Indication, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Biosimilar Monoclonal Antibody Market By Type, By Indication, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • August 2023
  • 293 Pages
  • Global
From
Global Biosimilars Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update - Product Thumbnail Image

Global Biosimilars Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update

  • Report
  • August 2023
  • 1300 Pages
  • Global
From
Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region - Global Forecast to 2028 - Product Thumbnail Image

Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region - Global Forecast to 2028

  • Report
  • June 2023
  • 298 Pages
  • Global
From
Ranibizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Ranibizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 150 Pages
  • Global
From
Pegfilgrastim- Biosimilar Insight, 2022 - Product Thumbnail Image

Pegfilgrastim- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Biosimilars World Market - Product Thumbnail Image

Biosimilars World Market

  • Report
  • January 2023
  • 28 Pages
  • Global
From
Loading Indicator